PMID: 9187465Jan 1, 1997Paper

Pelvic exenteration for the treatment of gynecological malignancies

Archives of Gynecology and Obstetrics
F NumaK Naito

Abstract

Twenty-three patients undergoing pelvic exenteration for primary and recurrent gynecological malignancies from 1976 to 1994 are reported. Fifteen patients underwent total pelvic exenteration, 3 underwent anterior exenteration, and 5 underwent a posterior procedure. Eight patients had exenteration as their primary treatment (primary group), and 15 underwent exenteration as secondary treatment (recurrent group). In the primary group, two patients developed recurrence and died of it at 6 and 20 months after operation. Five patients are still being followed up and are alive without disease. Four of these 5 patients have survived more than 5 years. In the recurrent group, 12 patients were followed up and three died of complications during the early years. Seven patients died of cancer with the mean survival time of 16.6 months. The mean age, average operating time, and mean blood loss in the primary and recurrent groups were 57 vs. 53 years, 8 hours and 20 min vs. 8 hours and 10 min, and 4,120 vs. 4,190 ml, respectively. The overall cumulative 5-year survival rate was 34.7%, being 68.6% in the primary group and 16.7% in the recurrent group. It is noteworthy that the 5-year survival rate was 51.3% in the patients who had surgical mar...Continue Reading

References

Dec 15, 1977·American Journal of Obstetrics and Gynecology·F N RutledgeA G O'Quinn
Jun 1, 1988·Journal of Surgical Oncology·H Rodriguez CuevasL Herrera
Jan 1, 1995·Gynecologic and Obstetric Investigation·Y NakamuraH Kato
Jan 7, 1995·Lancet·N Saunders
Nov 1, 1994·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·J.H. ShepherdW.F. Hendry

❮ Previous
Next ❯

Citations

Dec 17, 2003·Gynecologic Oncology·C PomelD Castaigne
Jan 10, 2013·The Oncologist·Joanie Mayer Hope, Bhavana Pothuri
Feb 14, 2013·International Journal of Clinical Oncology·Sota TanakaNobuo Yaegashi
Feb 15, 2016·Journal de gynécologie, obstétrique et biologie de la reproduction·H SardainJ Levêque
Jan 3, 2016·Journal of Minimally Invasive Gynecology·Shailesh PuntambekarShivam Vatsal
Jul 24, 2012·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·G BaiocchiA Lopes
Sep 9, 2008·Gynecologic Oncology·Laszlo UngarZoltan Novak
May 30, 2013·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·K K TanM J Solomon
Aug 8, 2006·Gynecologic Oncology·Simone MarnitzAchim Schneider
Feb 18, 2006·Gynecologic Oncology·Brian M SlomovitzCharles Levenback
Apr 30, 2015·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·H SardainJ Levêque
Jan 25, 2011·Gynecologic Oncology·Kate A McLeanBarbara A Goff
Feb 12, 2017·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Dominique KoensgenAlexander Mustea
May 2, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·F H van WijkHelena C van Doorn
May 9, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Anna GermanovaDavid Cibula
Mar 15, 2006·World Journal of Gastroenterology : WJG·Dariusz WydraAndrzej Marciniak
Nov 18, 2009·Acta Obstetricia Et Gynecologica Scandinavica·Johanna U MäenpääTiina Luukkaala
Jan 31, 2021·Journal of Robotic Surgery·Vandana JainSudhir Rawal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.